Lazarowski E R, Harden T K
Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill 27599.
J Biol Chem. 1994 Apr 22;269(16):11830-6.
Incubation of C6-2B rat glioma cells with UDP or UTP resulted in a time- and concentration-dependent increase in the accumulation of inositol phosphates. In contrast, ATP, ADP, and analogs of these nucleotides known to be effective agonists at P2U-, P2X-, P2Y-, P2T-, and P2Z-purinergic receptors all had no effect on inositol phosphate levels in C6-2B cells. Pyrimidine nucleotides stimulated inositol phosphate accumulation with an order of potency of UDP > 5-BrUTP > UTP > dTDP > UDP glucose. K0.5 values for UDP, 5-BrUTP, and UTP were 2.3 +/- 0.5, 9 +/- 3, and 57 +/- 10 microM, respectively. A similar uridine nucleotide selectivity was observed for arachidonic acid release presumably occurring as a consequence of activation of phospholipase A2. Cross-desensitization and additivity experiments indicated that UDP and UTP interact with the same population of receptors. The effect of uridine nucleotides on inositol phosphate accumulation was inhibited markedly by pretreatment of cells with pertussis toxin. UDP also caused a guanine nucleotide-dependent increase in inositol lipid hydrolysis in streptolysin-O-permeabilized cells. Taken together these results describe the existence of a novel uridine nucleotide receptor that is not activated by adenine nucleotides. This receptor is pharmacologically distinct from the previously described P2U- and other P2-purinergic receptors, and likely is a member of a new class of receptors for extracellular nucleotides.
用UDP或UTP孵育C6 - 2B大鼠胶质瘤细胞,可导致肌醇磷酸积累呈时间和浓度依赖性增加。相比之下,ATP、ADP以及已知在P2U -、P2X -、P2Y -、P2T -和P2Z -嘌呤能受体上作为有效激动剂的这些核苷酸类似物,对C6 - 2B细胞中的肌醇磷酸水平均无影响。嘧啶核苷酸刺激肌醇磷酸积累的效力顺序为UDP > 5 - BrUTP > UTP > dTDP > UDP葡萄糖。UDP、5 - BrUTP和UTP的半最大效应浓度(K0.5)值分别为2.3±0.5、9±3和57±10微摩尔。对于可能因磷脂酶A2激活而发生的花生四烯酸释放,也观察到了类似的尿苷核苷酸选择性。交叉脱敏和相加实验表明,UDP和UTP与同一群受体相互作用。用百日咳毒素预处理细胞可显著抑制尿苷核苷酸对肌醇磷酸积累的影响。UDP还可使经链球菌溶血素 - O通透处理的细胞中肌醇磷脂水解呈鸟嘌呤核苷酸依赖性增加。综上所述,这些结果表明存在一种新型尿苷核苷酸受体,它不会被腺嘌呤核苷酸激活。该受体在药理学上与先前描述的P2U -和其他P2 -嘌呤能受体不同,可能是细胞外核苷酸新一类受体的成员。